Exalys Therapeutics

About:

Exalys Therapeutics is focused on the development of first-in-class therapies for the treatment of inflammatory disorders.

Website: https://exalystx.com/

Top Investors: Domain Associates, Catalys Pacific

Description:

Exalys Therapeutics is developing a portfolio of novel anti-inflammatory therapeutics with best-in-class properties to target a range of diseases with urgent unmet needs and limited treatment options. Exalys is initially targeting postoperative delirium, the most common complication of surgery in older patients and a key driver of poor health outcomes.